SEC Tracker
Get the app
PODD · XBRL financial data

Insulet financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PODD's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue433510*442489544598*569649706784*762802
Cost of goods and services sold139149*135158167167*160197196215*233239
Gross profit293361*307331377431*409452510569*529563
Research and development5842*50545561*60737791*9088
Selling, general and administrative181213*200222234261*261258315331*317345
Operating income (loss)55106*575588109*89121118146*122130
Interest income96*991110*101096*54
Interest expense107*1111129*9201615*1514
Other income (expense)12*(1)(2)(3)0*(2)1123*1(1)
Income tax expense (benefit)25*3(138)511*1363539*2224
Net income (loss)52103*5218978101*352388102*9195
Earnings per share, basic USD per share0.741.48*0.742.691.111.44*0.500.321.241.44*1.301.37
Earnings per share, diluted USD per share0.74—0.732.591.081.36*0.500.321.241.41*1.301.37
Weighted average shares, basic millions of shares7070*70707070*70707070*7069
Weighted average shares, diluted millions of shares7481*74747474*74717172*7069

Balance sheet

CSV

Fiscal quarters (PODD's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents6857047518219039531,2831,122757716480535
Accounts receivable—————————517545589
Inventory411403431431445430441447446453463485
Prepaid and other current assets105116116148138142202267—228222241
Total current assets1,4711,5831,6181,7491,8611,8912,3282,2801,8591,9141,7101,849
Right-of-use asset2928———37———44——
Goodwill525252525252525252525252
Total assets2,4682,5882,6242,8823,0253,0883,5173,4693,0293,1902,9873,165
Accounts payable78197677402058964875150123
Accrued liabilities—————————587519602
Current portion of long-term debt5049393842848346180181919
Total current liabilities4514514324865065285201,010648680688744
Lease liability, non-current3030———40———49——
Total liabilities1,8601,8561,8331,8831,9071,8762,1872,0061,6451,6751,6851,743
Retained earnings (accumulated deficit)(481)(378)(327)(138)(60)407698186287379474
Total stockholders' equity6087337919981,1181,2121,3311,4631,3841,5151,3031,422
Total liabilities and equity2,4682,5882,6242,8823,0253,0883,5173,4693,0293,1902,9873,165
Common shares outstanding (cover page) millions of shares707070707070707070706969

Cash flows

CSV

Fiscal quarters (PODD's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)52103*5218978101*352388102*9195
Stock-based compensation11*13*1417*18*20*188*17*20*2120*
Depreciation and amortization19*19*1919*21*22*2222*22*24*2627*
Net cash from operating activities56*45*8897*99*148*64197*126*183*11488*
Purchases of property and equipment20*29*2223*27*54*1219*26*135*2433*
Net cash from investing activities(23)*(32)*(24)(25)*(29)*(68)*(16)(23)*(31)*(153)*(28)(37)*
Share repurchases—year only——0*0*030*30*0*3000*
Net cash from financing activities(7)*2*(14)(1)*8*(21)*278(344)*(457)*(73)*(320)4*
Net change in cash25*19*4770*82*51*330(162)*(364)*(41)*(236)55*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Insulet53580288*69.4M— 10-QJun 30, 2026
MiniMed Group207843(49)281.3M2.3 quarters 10-QJul 31, 2026
STERIS4821,49336797.5M— 10-QJun 30, 2026
Zimmer Biomet Holdings4102,177448*190.7M— 10-QJun 30, 2026
Baxter International1,9752,976558*517.3M— 10-QSep 30, 2026
West Pharmaceutical Services464875190*69.7M— 10-QSep 30, 2026
GE HealthCare Technologies2,8265,513907*452.1M— 10-QSep 30, 2026
Dexcom9611,345326*373.0M— 10-QSep 30, 2026
Resmed1,0111,415422140.7M— 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.